Posts

7 days in healthcare (October 31st-November 6th, 2022)

 

Summary

From the point of view of Biomedicine, the start of human trials of drugs discovered by Artificial Intelligence should be highlighted, something that is attracting the attention of all Big Pharma companies.

With regard to Global Health, it should be noted that COP27, the major international conference on climate change, will be held in Cairo on November 7 and 8. His opening coincides with the editorial in The Economist in which he says that the goal of keeping the temperature from rising 1.5º is totally unrealistic, proposing various alternatives. Ukraine’s health system prepares for nuclear disaster. Cholera outbreaks in various parts of the world.

Regarding International Health Policy, the WHO publishes a document on the development of telemedicine in Europe, identifying the problems of the user, technology and infrastructure as the main obstacles to its development. Problems in the British and French health systems.

If we talk about National Health Policy (Spain), the CESM denounces the proliferation of contracts for doctors without a MIR system. Surprisingly, there is no exact figure for how many doctors practice in Spain without MIR. Serious tensions in the Madrid healthcare system, mainly in out-of-hospital emergencies, although not only. It seems that the politics of confrontation prevails, which is neither positive nor desirable. There are no good memories of the famous “white tides” in Madrid, which should not be reactivated. The debate on the delay in access to medicines continues. The Ministry of Health affirms that part of this delay is due to pharmaceutical companies, which prioritize some countries over others in their marketing requests. At the national level, mention must be made of the death of Dr. Fernando Alonso-Lej, the great introducer of the MIR system in Spain and, therefore, deserving of maximum recognition.

In the Corporate arena, internationally J&J acquires a cardiac device company. In our country, it should be noted that the private sector builds more than 80% of nursing homes.

Biomedicine

Global Health

International health policy

National health policy

Companies

7 days in healthcare (September 5th-11th, 2022)

 

Summary

From the point of view of Biomedicine, to highlight the work that shows an association between artificial sweeteners and increased cardiovascular risk. Also that air pollution causes lung cancer.

As far as Global Health is concerned, apart from the serious humanitarian crises in Pakistan and Somalia, the most promising is the new malaria vaccine, which could be operational as early as 2023.

Regarding international health policy, assisted suicide and euthanasia are news in Canada (where the rate of euthanasia is very high and there is concern) and in France (which is considering passing a law). Macron has launched a major national debate on this issue, following a report to appear next week from the Ethics Committee. This great debate on such a delicate subject was missed in Spain. Certain issues should not be subject only to conjunctural parliamentary majorities, but should be preceded by a great national debate. It is also worth mentioning that Chile rejected the draft Constitution in a referendum. According to an article published in El País, doubts about the possibility of choosing the health system (the continuity of the ISAPRES, as health insurers are called in Chile), is one of the causes of this rejection.

If we talk about national health policy (Spain), it should be noted that Aragón proposes a great debate on the efficiency of the National Health System, a brave and valuable initiative. It will first analyze the Aragonese health system, and then share that analysis with the rest of the autonomies. Also that the Ministry of Health promises to change the law to favor the local manufacture of medicines. It is also worth underlining the pronouncement of the Catalan Evaluation Agency, on the need for a state policy for the digital transformation of the health system and the promotion of telemedicine.

In the field of companies, from the international point of view, to mention the purchase of Signify a home care group by CVS (an American pharmaceutical chain), in a process in which Amazon also showed interest. In terms of news at the national level, to highlight the great investment of Novartis in our country.

Biomedicine

Global Health

International health policy

National health policy

Companies

 

7 days in healthcare (May 9th-15th, 2022)

 

Summary

From the point of view of biomedicine, the important study published by the journal Science should be highlighted, outlining the most detailed atlas of human cells to date. The discussion about the origin of acute childhood hepatitis continues.

As far as Global Health is concerned, it is found that the United States has reached one million deaths from COVID and Europe two million. A sad milestone.

Regarding international health policy, in relation to COVID, the debate continues on the sustainability of the zero-COVID policy in China. Lockdowns in North Korea, possibly the most opaque country in the world. The debate continues in the United States on the modification of the Roe v Wade sentence. Pronouncements from scientific journals (Nature, The Lancet), as well as from the President of the American Medical Association. The ECDC (European Center for Disease Prevention and Control) stops recommending the use of masks on public transport in Europe.

If we talk about national health policy (Spain), the accumulated incidence of COVID continues to grow. Great debate regarding the announced new Abortion Law. It is more than doubtful that the Law will be approved and, if it is, that it will be complied with, given the large number of controversial elements (registration of conscientious objectors, the obligation that these interventions be carried out in public hospitals, the use of terminology of obstetric violence, etc.). The Ministry of Industry takes out the first tender of the cutting-edge health PERTE. Important editorial in El País on waiting lists, which it presents as a scourge of the SNS.

In the field of companies, the WHO denounces attempts to whiten tobacco companies, by way of presenting themselves as green companies.

Biomedicine

Global Health

International health policy

  • COVID-19

o The Director of the WHO affirms that the zero-covid policy in China is not sustainable (https://www.ft.com/content/9b81b9f0-e13d-4b0a-8bdf-91c97c7d61e7)

o A study says that lifting the “zero COVID” policy in China could mean 1.5 million deaths (https://www.theguardian.com/world/2022/may/11/lifting-zero-covid-policies-in -china-could-risk-16m-deaths-says-study)

o China considers the WHO statement on its zero COVID policy “irresponsible” (https://www.ft.com/content/2e20867b-5f1d-4307-93b0-1d9b07d65e34)

o China renounces organizing the 2023 Asian Soccer Cup, due to the pandemic (https://www.lemonde.fr/international/article/2022/05/14/la-chine-renonce-a-organiser-la- coupe-d-asie-2023-de-football-in-raison-de-la-pandemie-de-covid-19_6126096_3210.html)

o Confinement in North Korea, as the first cases of COVID are confirmed (https://www.ft.com/content/41dec58c-3860-4ae3-86c4-716ffe85dbdd)

o Alert in the state of New York, due to the increase in cases (https://www.nytimes.com/live/2022/05/13/world/covid-19-mandates-vaccine-cases)

  • The debate on abortion continues in the United States

o The pronouncement of medical and scientific journals continues against the annulment of the Roe v Wade ruling in the United States, for reasons of public health and worsening of the health of women and children, particularly those with fewer resources. Editorials in Nature (https://www.nature.com/articles/d41586-022-01249-2) and The Lancet (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22) 00870-4/fulltext), among others.

o Gerald E. Harmon, President of the AMA, the representation of American doctors, was “deeply concerned” about the impact on reproductive health in the United States of this possible modification (https://www.ama-assn.org/ delivering-care/population-care/why-leaked-abortion-opinion-antithetical-public-health)

o The New York Times assures that the annulment of same-sex marriage could be the next step (https://www.nytimes.com/2022/05/11/us/politics/roe-wade-supreme-court- abortion.html)

o Certain groups try to ban telemedicine prescription of pills that interrupt pregnancy (https://www.ft.com/content/6a3dd70e-8bb9-4727-af4a-4036a660db64)

  • Other themes

o The United States, willing to share vaccine technology with poor countries, says Biden (https://www.ft.com/content/ec6b5b3a-7cff-4aa9-8e68-cba3bbaae06f)

o The European Union Aviation Safety Agency and the European Center for Disease Prevention and Control (ECDC), eliminate the recommendation to use masks in airports and during flights (https://www.larazon.es/ society/20220511/2dur4ogv7zemfkl5bbwmsitpme.html)

o Disposable electronic cigarettes are imposed among adolescents in France (https://www.lemonde.fr/societe/article/2022/05/08/les-cigarettes-electroniques-jetables-s-imposent-parmi-les-adolescents_6125199_3224 .html)

o France will stop requiring a mask on public transport starting next Monday, May 16 (https://www.expansion.com/economia/2022/05/12/627ccd8e468aeb71118b4611.html)

National health policy

  • COVID

o The accumulated incidence continues to rise, growing 13 points since the last measurement and standing at 856.65 cases in the last 14 days per 100,000 inhabitants. The ward occupancy rate is 5.80% and the ICU occupancy rate is 4.07% (https://www.consalud.es/pacientes/especial-coronavirus/covid-19-espana-suma-31036-casos- 321-deceased-ia-uploads-856-points_114645_102.html)

  • Regulatory announcements

o The Government willing to approve next Tuesday, May 17, a new abortion law at the initiative of the Ministry of Equality. The 14-week period for abortion to be considered legal is not modified. Most controversial points: 1. Without permission or information to parents from the age of 16; 2. No to surrogacy; 3. Registration of conscientious objectors; 4. Abortion in public hospitals; 5. Leave due to painful menstruation, outside the regulations of the common disease; 6. The terminology of obstetric violence is maintained (https://www.abc.es/sociedad/abci-no-reforma-sino-ley-aborto-ultima-gobierno-diez-claves-rapidas-202205111920_noticia.html)

o The need to strengthen public healthcare so that it can address the 74,000 abortions that are performed in the private sector (https://elpais.com/sociedad/2022-05-14/la-sanidad-publica-debera-reforzarse-para-asumir -the-74000-abortions-that-now-derives-to-the-private.html)

o The Constitutional Court is preparing a ruling in favor of the 2010 Abortion Law for June, after an appeal by the PP, parked for 12 years (https://www.elconfidencial.com/espana/2022-05-13/constitucional-junio -judgment-favorable-law-abortion_3423623/)

  • Other themes

o The Ministry of Industry is putting out to tender the Vanguard Health PERTE for the pharmaceutical and health products sector (https://www.boe.es/boe/dias/2022/05/07/pdfs/BOE-B-2022-14280 .pdf)

o Important editorial in El País on waiting lists, which it presents as a major problem for the SNS (https://elpais.com/opinion/2022-05-10/largas-listas-de-espera.html)

o War of figures in the strike of medical specialists in Madrid (https://elpais.com/espana/madrid/2022-05-10/primer-dia-de-huelga-indefinida-de-medicos-en-madrid-basta -already-of-temporary.html)

o Castilla y León intends to lower the surgical delay in six months by 21 days (https://www.diariofarma.com/2022/05/11/castilla-y-leon-objetivo-bajar-21-dias-la-demora -surgical-in-6-months)

o The national 024 telephone line for suicide prevention is launched (https://www.larazon.es/sociedad/20220509/cubyq6iicncg3nfm6hieltpxvy.html)

o The SNS Interterritorial Council gives the green light to the Mental Health Plan (https://www.diariofarma.com/2022/05/11/el-cisns-da-luz-verde-al-plan-de-salud-mental -con-practica-unanimidad), which is criticized by the President of the Spanish Society of Psychiatry, saying that “Mental Health needs professionals and intermediate centers, not apps” (https://www.redaccionmedica.com/secciones/psiquiatria /-mental-health-needs-professionals-and-intermediate-centers-no-apps–8807)

o The Ministry publishes the list of 462 strategic medicines, which includes 249 active ingredients (https://www.diariomedico.com/farmacia/industria/estos-son-los-462-medicamentos-estrategicos-para-el-sns. html)

o Private doctors ask insurers to raise their fees, which according to them have been frozen for 32 years (https://theobjective.com/economia/2022-05-15/medicos-privados-honorarios/)

o Andalusia can have up to 8 Faculties of Medicine, after the steps in Jaén and Almería only Huelva remains (https://www.redaccionmedica.com/bisturi/-ocho-facultades-de-medicina-en-una-misma-region –3332), something (the proliferation of Medical Faculties) totally against the approaches of the CEEM (State Confederation of Medical Students) and the Conference of Deans

Companies, employers and other agents of the sector

  • International News

o The WHO asks countries to stop the tobacco companies that try to whitewash their image as a green industry (https://elpais.com/clima-y-medio-ambiente/2022-05-13/la-oms-pide- to-the-countries-that-stop-the-tobacco- companies-that-try-to-clean-up-their-image-as-a-green-industry.html)

o Pfizer will buy the biotech company Biohaven for 11.6 billion dollars (https://www.ft.com/content/ea9bb9bc-b5ec-4278-ab42-1f5f14a1a76f)

  • National News

o Vithas invests 3 million euros in the renovation of emergencies (https://www.plantadoce.com/empresa/vithas-madrid-la-milagrosa-invierte-tres-millones-de-euros-en-la-renovacion- of-your-emergencies.html)

o Vitaldent is committed to dental aesthetics by incorporating 73 Smysecret spaces into its clinics (https://www.plantadoce.com/empresa/vitaldent-apuesta-por-la-estetica-dental-e-incorpora-73-espacios-smysecret-a -your-clinics.html)

o Asisa buys a 600m2 center in Zaragoza (https://www.ondacero.es/programas/en-buenas-manos/asisa-compra-centro-medico-600-zaragoza_20220510627a3bbc64c3c90001106b03.html)

o Hospitales Parque grows in Talavera with a new building for outpatient consultations (https://www.plantadoce.com/empresa/hospitales-parque-crece-en-talavera-de-la-reina-con-un-nuevo-edificio- for-external-queries.html)

o Sanitas, SegurCaixa Adeslas and Línea Directa, the most profitable insurers (https://www.expansion.com/empresas/banca/2022/05/09/627567d7e5fdea58068b45f4.html)

o Novartis will manufacture an oncology drug for the whole world in Barcelona (https://www.eleconomista.es/salud/noticias/11765483/05/22/Novartis-fabricara-en-Zaragoza-un-oncologico-para-todo-el -world-.html)

7 days in healthcare (March 7-13, 2022)

 

SUMMARY

From the point of view of Biomedicine, the Lancet report on risk factors in COPD (chronic obstructive pulmonary disease), one of the great burdens of all health systems, should be highlighted. Also the finding that COVID can cause brain damage, although its scope is yet to be determined.

As for Global Health, it is worth noting the WHO complaint that 16 health facilities have been attacked in the war in Ukraine, as well as the organization’s statement that women should have access to safe abortions, to avoid mortality as well as hospitalizations due to complications.

When it comes to international health policy, the advice for the next pandemic contained in a major editorial in the Financial Times is important. There would be three priorities: 1. Reduce the risk of the appearance of a new pathogen (controlling the markets where animals are sold, for example); 2. Prevent it from spreading throughout the world; and 3. Develop an effective weaponry with vaccines and treatments as soon as possible. The incidence of COVID is increasing in England and France, just as the outbreak in China is the largest since the initial one in Wuhan. A report by The Lancet analyzes the mortality from COVID by country and even (as in the case of Spain) by region in the different countries. Spain is among the nations with the highest mortality from COVID per number of inhabitants. In the United Kingdom, a conservative think tank, with the support of the British Secretary of Health, proposes that primary care physicians become primarily salaried, thus breaking one of the fundamental elements of the political pact that gave rise to the NHS (on the one hand, hospitals are nationalized, but, on the other, the consideration of primary care physicians as independent mini-entrepreneurs is respected).

In national health policy, it is found that the drop in the incidence of COVID stagnates in Spain. Private healthcare, through the IDIS Foundation, considers the interoperability of the clinical history of private healthcare patients, regardless of insurer or provider.

Of the activity of the companies, an analysis of the Financial Times comments on how the economy of the pharmaceutical companies works against the development of antibiotics. Europe has lost the race against the United States in the development of new drugs. Important publication of the Roche Institute of a manual on personalized medicine aimed at health professionals.

BIOMEDICINE

GLOBAL HEALTH

INTERNATIONAL HEALTH POLICY

  • COVID

o Lessons for the next pandemic, after two years of covid, an important Financial Times editorial. Three priorities: 1. Reduce the risk of emergence of a new pathogen; 2. Prevent it from spreading throughout the world; and 3. Develop an effective weaponry with vaccines and treatments as soon as possible (https://www.ft.com/content/c9640c9c-5a65-49fa-a8b2-c22cc1ffe508)

o The COVID pandemic has lasted two years. Next steps may be divisive (https://www.nytimes.com/2022/03/12/us/covid-pandemic-vaccines-mandates.html)

o The covid does not decrease, but increases, in France (https://www.lemonde.fr/planete/article/2022/03/11/covid-19-olivier-veran-alerte-au-sujet-d-un -rebond-de-l-epidemie_6117120_3244.html)

o Covid cases and hospitalizations on the rise in England (https://www.theguardian.com/world/2022/mar/11/covid-cases-england-omicron-levels-ons-data)

o China, fighting the largest outbreak since Wuhan (https://www.ft.com/content/1e7dab0d-3247-4cb7-8370-e1697d70d693)

o Chinese scientists, in search of an alternative to the “zero COVID” policy, which the Chinese government boasts so much about (https://www.economist.com/china/2022/03/10/chinas-scientists-are-looking-for-a-way-out-of-the-zero-covid-policy)

o Where did the 5 “Trillion” (American) dollars of Covid stimulus go(https://www.nytimes.com/interactive/2022/03/11/us/how-covid-stimulus-money-was-spent.html)

o Mortality from COVID, three times higher than official figures (https://www.theguardian.com/world/2022/mar/10/global-covid-19-death-toll-may-be-three-times-higher-than-official-figures), according to a major report by The Lancet (http://www.thelancet-press.com/embargo/COVIDexcessmortality.pdf)

o Austria suspends the first universal vaccination obligation (https://www.ft.com/content/65650cbe-10b0-4350-8eb5-691624be8c2d)

  • Other topics

o The pandemic has accelerated the demand for private healthcare services in the UK (https://www.bmj.com/content/376/bmj.o566)

o The NHS app should be the new ‘gateway’ to the NHS, says UK health secretary (https://www.bmj.com/content/376/bmj.o621)

o British primary care physicians should be primarily salaried (https://www.bmj.com/content/376/bmj.o594), says a report by a conservative think tank (https://policyexchange.org.uk/publication/at-your-service/)

NATIONAL HEALTH POLICY (SPAIN)

  • COVID

o The drop in infections stagnates in Spain, with the incidence still at high risk, with 430.1 cases per 100,000 inhabitants, far from 50 (https://elpais.com/sociedad/2022-03-12/la-caida-de-contagios-de-covid-se-estanca-en-espana-con-la-incidencia-aun-en-riesgo-alto.html)

o Sánchez announces that the mandatory indoor mask will soon be abolished (https://www.rtve.es/noticias/20220306/sanchez-anuncia-pronto-se-supulsara-mascarilla-obligatoria-interiores/2303441.shtml)

o Spain destroys more than a million vaccines against covid, most of them from Janssen and AstraZeneca (https://www.elespanol.com/espana/politica/20220306/espana-destruye-vacunas-covid-19-mayoria-janssen-astrazeneca/654184713_0.html)

  • Political announcements

o Congress backs the proposal of the political party Ciudadanos for a law on ALS (https://www.larazon.es/sociedad/20220308/pvwdajf2yrgljceanzw4qgsr6a.html)

  • Other themes

o The Valencian health system carries out almost 600 sex change interventions in five years (https://www.eldiario.es/comunitat-valenciana/sanidad-valenciana-realiza-600-intervenciones-quirurgicas-cambio-sexo-cinco-anos_1_8822169.html)

o 9,932 candidates will be able to choose a MIR position (https://www.diariomedico.com/medicina/medico-joven/mir/9932-candidatos-podran-elegir-plaza-mir.html)

o The IDIS calls for more accessibility in Oncology (https://www.redaccionmedica.com/secciones/privada/el-idis-pide-un-modelo-de-organizacion-en-oncologia-accesible-y-equitativo-7382)

o Change in the General Directorate of Farmaindustria (https://cincodias.elpais.com/cincodias/2022/03/09/companias/1646826907_604545.html)

o The Royal National Academy of Medicine joins the European Academies of Medicine with a declaration on Ukraine (https://www.ranm.es/noticias/4799-declaracion-de-la-ranme-sobre-la-situacion-en-ucrania.html)

o Private healthcare invests 1.3 million euros to give private healthcare patients access to digital medical records in 2023 (https://www.elespanol.com/invertia/observatorios/sanidad/20220310/sanidad-privada-invierte-millones-pacientes-historia-clinica/656184536_0.html)

COMPANIES, EMPLOYERS AND OTHER AGENTS IN THE SECTOR

  • International News

o The Sacklers will pay $6 billion for Purdue’s opiate lawsuits (https://www.consalud.es/ecsalud/internacional/sacklers-pagaran-6000-millones-demandas-opiaceos-purdue_111017_102.html)

o Kirin goes beyond beer and goes into healthcare (https://www.ft.com/content/1d99a0be-6e76-4327-8516-da549a5f767e)

o How Pharmaceutical Economics Holds Back Antibiotic Development (https://www.ft.com/content/29292a3c-321d-4187-9ff0-59d70eb796f4)

o Europe loses the battle against the USA and only develops 22% of new medicines (https://cincodias.elpais.com/cincodias/2022/03/07/companias/1646677340_160102.html)

o Sanofi acknowledges that they were late for the covid vaccine (https://www.elmundo.es/ciencia-y-salud/salud/2022/03/13/6229d430fc6c832c328b4584.html)

  • National News

o Korian: 60 new beds and more purchases to bill one hundred million euros in Spain (https://www.plantadoce.com/empresa/korian-60-nuevas-camas-y-mas-compras-para-facturar-cien-millones-de-euros-en-espana.html)

o Europe asks HIPRA to expand its clinical trial of the covid vaccine (https://cincodias.elpais.com/cincodias/2022/03/07/companias/1646677340_160102.html)

o The Roche Institute publishes a personalized medicine manual for healthcare professionals (https://www.institutoroche.es/recursos/publicaciones/201/Propuesta_de_competencias_en_Medicina_Personalizada_de_Precision_de_los_profesionales_sanitarios)

 

 

 

7 days in healthcare (January 10-16, 2022)

 

SUMMARY

From the international point of view, several issues stand out. In the first place, the agreement of the French Assembly taken on Sunday, January 16, to prevent the access of the unvaccinated to leisure and restaurant premises; also Quebec’s initiative to introduce special taxes on the unvaccinated; the WHO’s opinion that it is too early for COVID “flu” policies, as proposed by Spain; the calculation by ISGlobal (Barcelona) that COVID has already left 17 million deaths globally; and the big push for research on neurodegenerative diseases.

As for national news, the SEMFYC (one of the Primary Care medical societies) editorial had a great impact defending the “flu” policies of COVID and, therefore, the minimization of measures, encouraging, consciously or unconsciously, the “light” negationism. This position was quickly adopted by the central government and certain authorities of the Community of Madrid. The central government even tried to lead this position at the international level. Rejection of this idea by other Primary Care societies, a large number of experts, the WHO and the EU. Meanwhile, the incidence of COVID continues to rise to figures never seen in other waves (2,923 cases per 100,000 inhabitants). The price of antigen tests is regulated, after multiple requests from various groups. It is agreed to extend the third and fourth doses. Serious problems regarding sick leave, for which solutions are articulated about the legality of which is in doubt. The purchase of COVID medicines is announced. Ayuso Plan to stimulate the birth rate in Madrid.

As far as companies and other actors are concerned, a group of scientists in Texas announce a vaccine against COVID, which, according to them, it will be cheaper, easier to make and patent-free. Pfizer announces that it will have a new vaccine against the “ómicron” variant ready in March

INTERNATIONAL NEWS

  • France: the Assembly approves by 215 votes against 58 the law that prevents the access of the unvaccinated to leisure and restaurant venues (Le Monde, Jan 16, 22)
  • Quebec’s plan on special taxes on the unvaccinated is well received in Europe. the argument is: “10% of the population cannot overload 90%”. Cold reception at the federal level in Canada and in other provinces. However, in Europe it is not receiving a bad reception: Greece and Austria already fine the unvaccinated, Italy is studying it, France extends the “covid passport” (BMJ, Jan 14, 22)
  • Fourth dose in Israel, which had already been announced for the immunosuppressed, is now being extended to health professionals and those over 60 years of age (Lancet Respir Med, Jan 11, 22)
  • The WHO considers that it is too early to treat COVID-19 as endemic, contradicting the Spanish government’s proposal, and predicts that half of Europeans can be infected (FT, Jan 11, 22)
  • COVID-19 pushed millions of Indians into poverty (The Economist, January 12,22)
  • Some experts predict a new COVID wave at the beginning of the summer (The Guardian, Jan 14, 22)
  • China’s zero COVID policy is creating problems for the manufacturing and distribution chain sectors (FT, Jan 16, 22)
  • Beijing reports the first case of the “ómicron” variant (The Guardian, Jan 15, 22)
  • COVID would have already left 17 million dead in the world (the official figures are 5.5 million), according to a study by the Barcelona Institute for Global Health, sponsored by the La Caixa Foundation (Diario Médico, Jan 15, 22)
  • The Epstein-Barr virus may play a role in the development of multiple sclerosis (NYT, Jan 13, 22)
  • The Economist looks at how healthcare is evolving into a consumer product (The Economist, Jan 15, 22)
  • Great boost to research on neurodegenerative diseases, with 260 drugs under development: Alzheimer’s, Amyotrophic Lateral Sclerosis (ALS), Huntington’s, multiple sclerosis, multiple systemic atrophy, Parkinson’s and others (Diariofarma, Jan 14, 22)

NATIONAL NEWS

  • Incidence of COVID and evolution of the sixth wave

o As of January 13, 2022, the 14-day cumulative incidence of COVID amounts to 2,923 cases/100,000 inhabitants. It is not clear if the peak of the wave has been reached or if we are still going up. In any case, the figures are very high (Official data Ministry of Health, update to  Jan 13, 22)

o Almost half of the Spanish provinces have ICUs at very high risk (El País, Jan 12, 22)

o The debate on those hospitalized “for” COVID and “with” COVID is introduced (El Independiente, Jan 10, 22)

  • “Influenzaization of the pandemic”

o An editorial in a journal of the SEMFYC (Spanish Society of Primary and Community Care Physicians), one of the three scientific societies of Primary Care, advocates the “influenza” approach  of the COVID, avoiding counting individual cases and omitting general measures of protection (AMF-SEMFYC, Towards the end of the exceptionality, Jan 10, 22)

o The other scientific societies of Primary Care, as well as most of the experts, took a stand against the previous proposal, at least until the sixth wave was passed.

o Notwithstanding the foregoing, both the President of the Government and Minister Darias, and certain representatives of the Community of Madrid, expressed their agreement with the approach as “influenza”

o Not only that, but that approach was taken to the WHO, which showed its disagreement. Spain wants to lead this debate in the EU (El Periódico de España, Jan 12, 22)

  • Regulation of the price of antigen tests

o The government (Interministerial Commission on the Price of Medicines) limits the price of antigen tests to 2.94 euros and they will continue to be sold only in pharmacies, with entry into force on Saturday, January 15, 2022. The price is 50% more expensive than in France and Germany (El País, Jan 13, 22)

o During the free sale period, the gross margin for pharmacies was 25-50% (El Economista, Jan 13, 22)

o FEFE expresses its “deep discomfort” at having to sell the tests at a loss (diariofarma, Jan 14, 22)

  • The third and fourth doses are extended

o The Ministry of Health announces a fourth dose for patients at risk and will extend the third to those over 18 years of age (La Razón, Jan 13, 22)

  • Purchase of COVID medications

o Spain closes an agreement with Pfizer to buy 344,000 doses of its drug against COVID

o The regions were unaware of this and ask for an equitable distribution (El Español, Jan 11, 22)

  • Serious problem with sick leave

o COVID causes more than 10,000 sick leaves per day in Spain (El Independiente, Jan 11, 22)

o This situation collapses health centers

o A system is put in place so that discharge and discharge (after 7 days) take place in the same act. Madrid calls for a regulatory change, to which the Government does not seem willing (El Economista Jan 12, 22)

  • Ayuso Plan to stimulate the birth rate in Madrid

o It is intended to go from 50,000 to 70,000 births/year in the region. The plan consists of aid of 500 euros, flexible working hours, deductions and support for assisted reproduction (La Razón, Jam 10, 22)

  • Other themes

o FACME disagrees with the recertification plan of the Ministry of Health, which launched a tender to hire a consultant (Official note from FACME,  Jan 13, 22)

o Teachers facing the return to classes, doubts with the new protocol and fears (El País, Jan 10, 22)

o A court condemns the Generalitat Valenciana to compensate the toilets for not giving them the means of protection (El País, Jan 11, 22)

o Ingesa attempts an agreement on biosimilars, which does not have the agreement of BIOSIM (diariofarma, Jan 9, 22)

COMPANIES, EMPLOYERS AND MAIN ACTORS IN HEALTH

  • A group of scientists in Texas announce a vaccine (CORBEVAX) that is cheaper, easier to make and patent-free (The Guardian, Jan 15, 22)
  • GSK rejects UNILEVER’s offer of 50,000 million pounds for its consumer division (FT, Jan 15, 22)
  • Medicare introduces major restrictions on the use of Biogen’s drug against Alzheimer’s (NYT, Jan 11, 22)
  • Adeslas will enter 1,655 million euros for MUFACE and ASISA 1,268 (PlantaDoce, Jan 12, 22)
  • Vivanta adjusts its network of centers, putting its beauty business up for sale (PlantaDoce, Jan 12, 22)
  • Pfizer says that it will have a new vaccine against “ómicron” ready in March (Redacción Médica, Jan 10, 22)
  • Merck acquires the US company EXELEAD for 789 million dollars (PlantaDoce, Jan 7, 22)
  • Medtronic reaches an agreement to acquire Affera (ConSalud, Jan 14, 22)
  • Eugin acquires the Delaware Institute of Reproductive Medicine (PlantaDoce, Jan 10, 22)
  • Caser Residencial acquires a new social health center in Laguna de Duero (PlantaDoce, Jan 13, 22)

Which Country Has The World’s Best Health Care?

 

 

 

The famous physician, health economist and bioethicist, Ezekiel J. Emanuel, has recently published a book (Public Affairs, New York, 2020) that tries to answer the famous question of what is the best healthcare system in the world. Obviously, after a long exploration, the answer is that there is no system that can be classified as the best in the world, but rather that they all have their strengths and weaknesses.

But the exploration is not without interest, since he analyzes with some detail, the systems of 11 countries: the United States, Canada, the United Kingdom, Norway, France, Germany, the Netherlands, Switzerland, Australia, Taiwan and China. Very much in the Anglo-Saxon tradition, Spain does not exist and, what is even more surprising, none of the Latin American and Caribbean countries.

The book analyzes the 7 challenges that healthcare systems usually face:

  1. Cost pressure
  2. The price of medicines
  3. Inefficiency in the provision of services
  4. Coordination of patients with chronic diseases
  5. Mismatch between the organization of provision services and the needs of chronic patients
  6. Provision of mental care
  7. Long-term care

The book has very interesting graphs that analyze: a) the different types of coverage in each country; b) financing and origin of funds; c) the system of payment to hospitals and doctors; d) organization of provision (including hospital care, outpatient care, mental care, long-term care and prevention); e) pharmaceutical coverage and price control; and, finally, f) human resources.

The challenges of each country are analyzed objectively.

7 days in healthcare (1-7 november, 2021)

 

 

ABSTRACT

From an international point of view, to highlight something we knew: that WHO, in its current configuration, is not prepared for global health challenges. However, this finding is important in the article in the British Medical Journal by Anthony Costello. Europe, once again in the center of expansion of the pandemic. The decision of the North American Democrats to reduce the price of medicines, via the negotiation in Medicare, is very far-reaching. This decision, if applied, will have major consequences for the entire pharmaceutical industry globally.

At the national level, to highlight the article in The Lancet, which says that Spain could have achieved group immunity. For the rest, the incidence of COVID continues to grow in our country, although it does not reach, by far, those of other European countries. Waiting lists are a big concern throughout Spain. Controversy over the new Equity, Universalization and Cohesion Law. Podemos wants to take advantage of it to repeal Law 15/1997, which allows the outsourcing of health services.

As a business activity, to highlight the two new antivirals against covid-19, one from Merck and the other from Pfizer. Merck has released the patent so that it can be used widely in developing countries. Novartis dissociates itself from Roche, selling it its 33% stake in the latter company.

INTERNATIONAL

  • The WHO, in its current configuration, is not ready for its purpose, but is limited by lack of funds and political interference, and this has been demonstrated in this pandemic that has produced more than 18 million deaths, writes the economist Anthony Costello in the British Medical Journal (BMJ, 3 Nov 21)
  • Europe once again at the center of the covid pandemic, says WHO, (The Guardian, 4 Nov 21)
  • The WHO warns of the increase in deaths from covid in 56 countries, and insists that vaccine manufacturers have not done their job well (ConSalud, 5 Nov 21)
  • Democrats in the United States reach an agreement to reduce the price of drugs, allowing the government to negotiate the price of Medicare drugs. The United States pays three times more for many drugs than Europe, according to a study by the Brookings Institution. Initially, the measure will be launched with the 12 most expensive drugs (FT, 2 Nov 21)
  • The fourth wave continues to beat the record of infections in Greece, with almost 7,000 daily (El Confidencial, 6 Nov 21)
  • Excess mortality grows in Russia, since the beginning of the pandemic (FT, 2 Nov 21)
  • The management of the pandemic leaves a trail of investigated political leaders: Brazil, France, Italy, Austria, India, … (El Debate, 2 Nov 21)
  • India’s successes against covid are analyzed: more than half of Indians have received at least one dose of the vaccine. 6 million are vaccinated every day (The Economist, 29 Oct 21)

NATIONAL

 

  • The Lancet suggests that Spain could have achieved group immunity. They are based on the high infections and the high percentage of vaccination (La Razón, 3 Nov 21)
  • The incidence of covid rises more than two points, to 53.7 cases per 100,000 inhabitants (El País, 5 Nov 21)
  • Madrid for the first time exceeds half a million patients to see the specialist. Experts warn that the pandemic has generated in Spain a dammed demand that will emerge in the coming semesters (El País, 5 Nov 21)
  • Spain, one of the five countries in which Covid-19 caused the greatest loss in life expectancy, according to a study published by the British Medical Journal (ABC, 3 Nov 21)
  • The Health Ministry sells a million vaccines to Australia, New Zealand and Paraguay, before they expire (El Español, 2 Nov 21)
  • The WHO requests to increase oral public coverage in Spain (Health Act. The proposal receives the support of the General Council of Dentists (Health Act, 5 Nov 21)
  • Podemos will not support the Darias Equity Law. The Ministry wants to promote a Law of Equity, Universality and Cohesion and Podemos does not support it by not repealing Law 15/1997, which allows the outsourcing of health services (ConSalud, 5 Nov 21)
  • The Health Ministry seeks location for its strategic reserve of covid material (El Periódico de España, 5 Nov 21)

COMPANIES, EMPLOYERS AND MAIN ACTORS IN HEALTH

 

  • Merck drug effective to treat covid-19. The drug is an oral antiviral, called molnupiravir, and has already been approved by the British Agency. It has been launched by Merck and Ridbback Biotherapeutics, a Florida-based biotech. The drug is indicated for the unvaccinated and for those vaccinated who develop the disease. The treatment will be worth US $ 700 in developed countries. Merck will allow the development of generics in 105 countries (The Economist, 4 Nov 21)
  • Alphabet, Google’s parent company, launches an AI company, Isomorphic Labs, for the discovery of new drugs. It will work together with DeepMinds, Google’s AI company (FT, 4 Nov 21)
  • Pfizer increases the sales forecast of its covid vaccine in 2021 to 36,000 million US $ (FT, 2 Nov 21)
  • Biogroup, a bioanalysis group piloted by Stéphane Eimer and with a presence in Belgium, Luxembourg and the United Kingdom, enters the Iberian Peninsula with the purchase of Cerba Internacional and Analiza (both owned by Marcelo Weisz). ASISA will retain its 50% stake in Analiza (Les Echos, 4 Nov 21)
  • Novavax, a protein-based American covid-19 vaccine, receives its first approval in Indonesia. May promote immunization in developing countries. An application for authorization has also been sent to Canada, the United Kingdom and the European Union (FT, 1 Nov 21)
  • Pfizer announces an antiviral pill (Paxlovid) that prevents 89% of hospitalizations and deaths from covid (El País, 5 Nov 21)
  • The Valencian government will propose to the Data Protection Agency a sanction to Ribera for withholding data from the Torrevieja hospital (eldiario.es, Nov 4 21)
  • Centene closes the year of the coronavirus with losses in its health adventure in Spain (Nov 6, 21)
  • “Son Espases”: the macro-investigation on the concession to OHL of this hospital in the Balearic Islands, which links the Balearic Islands with the illegal financing of the PP (eldiario.es, Nov 5, 21)
  • Novartis sells its 33% stake to Roche for more than US $ 20 billion. A relationship of more than twenty years between the two companies is ended (PlantaDoce, Nov 4, 21)
  • MD Anderson launches a clinical trials unit (PlantaDoce, 3 Nov 21)
  • Eugin expands through Canada and acquires the fertility centers of Trio Fertility (PlantaDoce, 2 Nov 21)
  • Affidea, a European provider of diagnostic imaging, outpatient services and cancer care, expands in Spain and Northern Ireland with two new acquisitions (PlantaDoce, Nov 3, 21)
  • The biotechnology company of Spanish origin Aura Biosciences, jumps to the Nasdaq (PlantaDoce, 3 Nov 21)
  • Rovi doubles its profit in the first nine months of 2021, to 99 million (PlantaDoce, 3 Nov 21)